Search Results - "Wiezer, René"

Failed Sleeve Gastrectomy: Single Anastomosis Duodenoileal Bypass or Roux-en-Y Gastric Bypass? A Multicenter Cohort Study by Dijkhorst, Phillip J., Boerboom, Abel B., Janssen, Ignace M. C., Swank, Dingeman J., Wiezer, René M. J., Hazebroek, Eric J., Berends, Frits J., Aarts, Edo O.

“…Background Sleeve gastrectomy (SG) has become the most performed bariatric procedure to induce weight loss worldwide. Unfortunately, a significant portion of…”
Get full text

Single Anastomosis Duodenoileal Bypass or Roux-en-Y Gastric Bypass After Failed Sleeve Gastrectomy: Medium-Term Outcomes by Dijkhorst, Phillip J., Al Nawas, May, Heusschen, Laura, Hazebroek, Eric J., Swank, Dingeman J., Wiezer, René M.J., Aarts, Edo O.

“…Background Although the sleeve gastrectomy (SG) has good short-term results, it comes with a significant number of patients requiring revisional surgery…”
Get full text

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity by Laoukili, Jamila, Constantinides, Alexander, Wassenaar, Emma C. E., Elias, Sjoerd G., Raats, Danielle A. E., van Schelven, Susanne J., van Wettum, Jonathan, Volckmann, Richard, Koster, Jan, Huitema, Alwin D. R., Nienhuijs, Simon W., de Hingh, Ignace H. J. T., Wiezer, René J., van Grevenstein, Helma M. U., Rinkes, Inne H. M. Borel, Boerma, Djamila, Kranenburg, Onno

“…Background Peritoneal metastases (PM) in colorectal cancer (CRC) are associated with therapy resistance and poor survival. Oxaliplatin monotherapy is widely…”
Get full text

Implications for IV posaconazole dosing in the era of obesity by Wasmann, Roeland E, Smit, Cornelis, van Donselaar, Marieke H, van Dongen, Eric P A, Wiezer, René M J, Verweij, Paul E, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…Abstract Background The prevalence of obesity has shown a dramatic increase over recent decades. Obesity is associated with underdosing of antimicrobial drugs…”
Get full text

Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers by Brill, Margreke J. E., van Rongen, Anne, Houwink, Aletta P. I., Burggraaf, Jacobus, van Ramshorst, Bert, Wiezer, René J., van Dongen, Eric P. A., Knibbe, Catherijne A. J.

“…Background While in vitro and animal studies have shown reduced cytochrome P450 (CYP) 3A activity due to obesity, clinical studies in (morbidly) obese patients…”
Get full text

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals by Wasmann, Roeland E, Smit, Cornelis, van Dongen, Eric P H, Wiezer, René M J, Adler-Moore, Jill, de Beer, Yvo M, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…In this prospective study, we examined the pharmacokinetics of 1 and 2 mg/kg liposomal amphotericin B in 16 morbidly obese individuals (104-177 kg). Body size…”
Get full text

Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults by Wasmann, Roeland E, Smit, Cornelis, ter Heine, Rob, Koele, Simon E, van Dongen, Eric P H, Wiezer, René M J, Burger, David M, Knibbe, Catherijne A J, Brüggemann, Roger J M

“…Abstract Objectives The rising pandemic of obesity means an increasing number of obese patients who require antimicrobial therapy for serious infections…”
Get full text

Preoperative Weight Gain Is Not Related to Lower Postoperative Weight Loss, But to Lower Total Weight Loss up to 3 Years After Bariatric-Metabolic Surgery by Jacobs, Anne, Al Nawas, May, Deden, Laura N., Dijksman, Lea M., Boerma, Evert-Jan G., Demirkiran, Ahmet, Hazebroek, Eric J., Wiezer, M. (René) J., Derksen, Wouter J.M., Monpellier, Valerie M.

“…Introduction Weight loss prior to bariatric-metabolic surgery (BMS) is recommended in most bariatric centers. However, there is limited high-quality evidence…”
Get full text

An observational cohort of patients with colorectal peritoneal metastases or pseudomyxoma peritonei treated with CRS-HIPEC: Development and first results of the Dutch CRS-HIPEC quality registry by van Erning, Felice N., van den Heuvel, Teun B.M., Sijtsma, Femke P.C., Boerma, Djamila, Brandt-Kerkhof, Alexandra R.M., Bremers, André J., van Duyn, Eino B., van Grevenstein, Helma M.U., Hemmer, Patrick H.J., Kok, Niels F.M., Madsen, Eva, de Reuver, Philip R., Wiezer, René J., Witkamp, Arjan J., Nienhuijs, Simon W., Poelmann, Floris B., Tuynman, Jurriaan B., Been, Lucas B., Rovers, Koen P., de Hingh, Ignace H.J.T.

“…To improve care for patients with colorectal peritoneal metastases (CRC-PM) or pseudomyxoma peritonei (PMP), the Dutch CRS-HIPEC quality registry was initiated…”
Get full text

Population Pharmacokinetics and Pharmacodynamics of Propofol in Morbidly Obese Patients by van Kralingen, Simone, Diepstraten, Jeroen, Peeters, Mariska Y. M., Deneer, Vera H. M., van Ramshorst, Bert, Wiezer, René J., van Dongen, Eric P. A., Danhof, Meindert, Knibbe, Catherijne A. J.

“…Background and Objectives: In view of the increasing prevalence of morbidly obese patients, the influence of excessive total bodyweight (TBW) on the…”
Get full text

Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint by Diepstraten, Jeroen, Janssen, Esther J. H., Hackeng, Christian M., van Dongen, Eric P. A., Wiezer, René J., van Ramshorst, Bert, Knibbe, Catherijne A. J.

“…Purpose In absence of specific dosing guidelines, the optimal dose of low molecular weight heparins for thrombosis prophylaxis in morbidly obese patients (BMI…”
Get full text

Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients by Diepstraten, Jeroen, Hackeng, Christian M., van Kralingen, Simone, Zapletal, Jiri, van Dongen, Eric P. A., Wiezer, René J., van Ramshorst, Bert, Knibbe, Catherijne A. J.

“…Background Morbidly obese patients (BMI > 40 kg/m 2 ) are at increased risk for venous thromboembolism, especially after surgery. Despite limited evidence,…”
Get full text

Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study by Van Nieuwenhove, Yves, Dambrauskas, Zilvinas, Campillo-Soto, Alvaro, van Dielen, Francois, Wiezer, René, Janssen, Ignace, Kramer, Michael, Thorell, Anders

“…A 14-day very low-calorie diet (VLCD) regimen before a laparoscopic gastric bypass procedure will improve perioperative and postoperative outcomes…”
Get more information

Recurrent Left-sided Colon Volvulus Leading to Mediastinal Shift by Scheffer, Robert C.H, Wiezer, René J, Timmer, Robin

Get full text

First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II) by Rauwerdink, Paulien, van de Vlasakker, Vincent C.J., Wassenaar, Emma C.E., Rovers, Koen P., Los, Maartje, Herbschleb, Karin H., Creemers, Geert-Jan M., Thijs, Annemarie M.J., Raicu, Mihaela G., Huysentruyt, Clément J.R., van der Hoeven, Erik J.R.J., Nederend, Joost, Peeters, Rifka Y.M., Deenen, Maarten J., Elias, Sjoerd G., Fijneman, Remond J.A., Constantinides, Alexander, Kranenburg, Onno, Burger, Pim W.A., Nienhuijs, Simon W., Wiezer, René J., Lurvink, Robin J., de Hingh, Ignace H.J.T., Boerma, Djamila

“…Palliative systemic therapy alternated with electrostatic precipitation oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (ePIPAC) has never…”
Get full text

Costs of repetitive oxaliplatin-based electrostatic pressurized intraperitoneal aerosol chemotherapy (ePIPAC-OX) for unresectable colorectal peritoneal metastases by Lurvink, Robin, Rovers, Koen, Rauwerdink, Paulien, Burger, Pim, Wiezer, René, Nienhuijs, Simon, Boerma, Djamila, de Hingh, Ignace

Get full text

Patient-reported outcomes during repetitive pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase 2 trial by Lurvink, Robin, Rovers, Koen, Wassenaar, Emma, Bakkers, Checca, Burger, Pim, Creemers, Geert-Jan, Los, Maartje, Mols, Floortje, Wiezer, René, Nienhuijs, Simon, Boerma, Djamila, de Hingh, Ignace

Get full text

Palliative systemic therapy and oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with unresectable colorectal peritoneal metastases in a phase II trial (CRC-PIPAC-II) by Van De Vlasakker, Vincent, Rauwerdink, Paulien, Rovers, Koen P., Wassenaar, Emma C.E., Deenen, Maarten J., Nederend, Joost, Huysentruyt, Clément J.R., Fijneman, Remond J.A., van der Hoeven, Erik J.R.J., Raicu, Mihaela M., Constantinides, Alexander, Kranenburg, Onno, Los, Maartje, Creemers, Geert-Jan M., Burger, Pim W.A., Wiezer, René J., Nienhuijs, Simon W., Lurvink, Robin J., Boerma, Djamila, de Hingh, Ignace H.J.T.

Get full text

Weight loss after bariatric surgery: a comparison between delayed and immediate qualification according to the last resort criterion by Jacobs, Anne, Liem, Ronald S.L., Janssen, Ignace M.C., Tollenaar, Rob A.E. M., Monpellier, Valerie M., Demirkiran, Ahmet, van Veen, Ruben, Hazebroek, Eric, Greve, Jan Willem, Wiezer, René M., Swank, Dingeman, Knook, Mireille, Faraj, Dashti, Tseng, Larissa, de Castro, Steve, Marsman, Hendrik, van Tets, Willem, Cense, Huib, Tenhagen, Mark, Boerma, Evert Jan, Fransen, Sophie, Meesters, Berry, Wijffels, Niels, te Riele, Wouter, Derksen, Wouter, Takkenberg, Marijn, Aufenacker, Theo, Vening, Wouter, Witteman, Bart, den Hengst, Willem

“…In the Netherlands, patients only qualify for bariatric surgery when they have followed a 6-month mandatory weight loss program (MWP), also called the “last…”
Get full text

Rupture of infected peripancreatic necrosis to the peritoneal cavity with fatal outcome by Besselink, Marc G H, Bollen, Thomas L, Scheffer, Robert C H, Weusten, Bas L A M, Timmer, Robin, Wiezer, Rene M J, van Ramshorst, Bert

Get full text